Additional Manufacturers Seek Contract Pharmacy Data and Place Restrictions on 340B Programs
AstraZeneca distributed letters recently that as of October 1, 2020, 340B pricing will be available only through “a single contract pharmacy for those covered entities that do not maintain their […]
Read More